Biotechnology Turns To Ancient Remedies In Quest For Sources Of New Therapies

Sidebar: For Further Information - Alternative Medicine With consumer interest in "natural" remedies on the rise, some academic and corporate researchers have begun to look for new drugs among ancient remedies. Several such efforts focus on the rich, detailed pharmacopoeia of Chinese herbal medicine, which has been painstakingly recorded and passed on for generations. In contemporary China-as in much of the world-herbal concoctions remain the predominant form of medication. In the hands of West

| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

Sidebar: For Further Information - Alternative Medicine


BUDDING PROMISE: Sylvia Lee-Huang and colleagues have identified molecular mechanisms by which a protein derived from bitter melon, shown here, may act to suppress HIV infection.
These projects, though still in their infancy, grew out of the pharmaceutical industry's longtime practice of seeking drug leads in plants. Some of the many plant-based medicines include digitalis, from foxglove, used to treat congestive heart failure and cardiac arrhythmias; pseudoephedrine, from the Chinese herb ma huang (Ephedra spp.), a decongestant; and anticancer drugs vinblastine and vincristine, from the myrtle, Vinca rosea. Botanical compounds also provide leads for the development of synthetic pharmaceuticals.

Only a handful of biotech and pharmaceutical companies and academic researchers are pursing the development of therapeutics from Chinese herbal medicine. But some researchers in the field see great potential for its growth.

"Scientists have only been able to exhaustively examine approximately one-half of ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Alison Mack

    This person does not yet have a bio.

Published In

Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours